Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Ironwood Pharmaceuticals (IRWD) Interest & Investment Income: 2010-2025

Historic Interest & Investment Income for Ironwood Pharmaceuticals (IRWD) over the last 16 years, with Sep 2025 value amounting to $930,000.

  • Ironwood Pharmaceuticals' Interest & Investment Income fell 19.27% to $930,000 in Q3 2025 from the same period last year, while for Sep 2025 it was $3.4 million, marking a year-over-year decrease of 30.49%. This contributed to the annual value of $4.5 million for FY2024, which is 76.45% down from last year.
  • Per Ironwood Pharmaceuticals' latest filing, its Interest & Investment Income stood at $930,000 for Q3 2025, which was up 13.69% from $818,000 recorded in Q2 2025.
  • Over the past 5 years, Ironwood Pharmaceuticals' Interest & Investment Income peaked at $8.8 million during Q2 2023, and registered a low of $172,000 during Q2 2021.
  • For the 3-year period, Ironwood Pharmaceuticals' Interest & Investment Income averaged around $2.4 million, with its median value being $1.2 million (2024).
  • As far as peak fluctuations go, Ironwood Pharmaceuticals' Interest & Investment Income soared by 3,061.74% in 2023, and later tumbled by 84.37% in 2024.
  • Quarterly analysis of 5 years shows Ironwood Pharmaceuticals' Interest & Investment Income stood at $180,000 in 2021, then skyrocketed by 2,925.56% to $5.4 million in 2022, then crashed by 78.08% to $1.2 million in 2023, then tumbled by 34.84% to $778,000 in 2024, then decreased by 19.27% to $930,000 in 2025.
  • Its last three reported values are $930,000 in Q3 2025, $818,000 for Q2 2025, and $869,000 during Q1 2025.